14 results on '"Tomasiewicz, Krzysztof"'
Search Results
2. The most difficult to cure with pangenotypic regimens HCV infected population
3. Five-years follow-up of cured HCV patients with or without cirrhosis under real-world interferon-free therapy
4. Pangenotypic and genotype-specific antivirals in the treatment of genotype 4 infected patients with HIV coinfection
5. A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy
6. THU-215 - The most difficult to cure with pangenotypic regimens HCV infected population
7. Real-life efficacy and safety of direct-acting antivirals in patients with liver cirrhosis and history of hepatic decompensation: EpiTer-2 study
8. THU-140-Characteristics of patients and effectiveness of chronic hepatitis C treatment during the initial 4 years of access to interferon-free therapy
9. THU-196-Efficacy of 8 versus 12-weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-weeks regimen in real world setting
10. THU-148-Variability of selected extracellular matrix proteins concentrations in HCV infected patients treated with sofosbuvir and ledipasvir
11. THU-217-Low risk of HBV reactivation in a large European cohort of HBV/ HCV coinfected patients treated with DAA
12. THU-185-Effectiveness and safety of DAA-based treatment of hepatitis C patients with severe and end stage chronic kidney diseases-EpiTer-2 database analysis
13. THU-197-Comparative effectiveness of 8 versus 12 weeks of ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naive patients infected with HCV genotype 1b with non-advanced hepatic fibrosis
14. THU394 - Real-life efficacy and safety of direct-acting antivirals in patients with liver cirrhosis and history of hepatic decompensation: EpiTer-2 study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.